Cardinal Health Projects FY Adjusted EPS of $10.70-$10.80
Summary
Cardinal Health has issued its full-year adjusted EPS guidance, projecting a range of $10.70 to $10.80. This financial forecast is a key indicator for investors, directly influencing valuation models and future earnings expectations. This update follows the company's robust Q2 FY26 results reported in February. While the headline does not provide context relative to analyst consensus or previous guidance, this specific outlook from a reliable wire service is a material update for traders. Investors will closely monitor how this guidance aligns with market expectations and any further details provided by the company regarding its operational performance and outlook.
At the time of this announcement, CAH was trading at $208.38 on NYSE in the Life Sciences sector, with a market capitalization of approximately $47.7B. The 52-week trading range was $136.71 to $233.60. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.